Justin Stebbing

Justin joined Vitruvian in 2019 as a Managing Director in the Investment Team and is focused on the Life Sciences and Healthcare sector.

Prior to Vitruvian, Justin was an Analyst at Atticus Capital and Lansdowne Partners. He is also a Professor of Cancer Medicine and Oncology, has published over 700 scientific papers and is editor of Springer Nature’s journal, Oncogene. Justin has a medical degree (First class) from Trinity College, Oxford and PhD from Imperial College, London.